In Brief This Week: Hologic; GE Capital, Saladax; BD; PerkinElmer Health Sciences; Diaxonhit; More | GenomeWeb

NEW YORK (GenomeWeb News) – Hologic said this week it is seeking to amend its senior secured credit facilities in conjunction with a proposed refinancing of its existing secured tranche B term loan. As of July 22, 2013, the outstanding principal on the Term B loan, which has a maturity date of Aug. 1, 2019, is $1.489 billion. Hologic was scheduled to meet with prospective lenders on July 23 related to the credit facility refinancing.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.